Lesson 3 of 36 · 10 min
A short history of peptide medicine
Peptides did not appear with social media, biohacking or GLP-1 drugs. The field is more than a century old. Understanding that history makes it much easier to separate established peptide medicine from newer research.
The beginning
The story starts with hormones the body already makes.
Secretin was identified in the early 1900s, helping establish the idea that organs communicate through chemical messengers. Insulin followed in 1921 and rapidly changed diabetes from a usually fatal disease into a treatable one.
Early peptide medicines were isolated from natural tissues. That worked, but supply, consistency and manufacturing were difficult. The next breakthroughs came from learning how to determine peptide sequences and then build them deliberately.
1920s · Insulin
Insulin became the defining proof that replacing a peptide signal could produce a major clinical effect.
1950s · Synthetic oxytocin
Oxytocin became a landmark in peptide chemistry because scientists could reproduce a biologically active peptide by chemical synthesis.
1960s onward · Better synthesis
Solid-phase peptide synthesis and later recombinant technologies made peptide production faster, cleaner and more scalable.
Modern era · Designed analogues
Today many successful peptide drugs are modified versions of natural signals, engineered for longer action, better stability or different delivery.
Why this matters
Modern peptide drugs are usually engineered, not simply copied.
Natural peptides are often broken down quickly. Drug developers can change amino acids, attach fatty-acid chains, alter structure or use delivery technology to extend half-life and improve how a molecule behaves.
That is why a modern peptide medicine may act on the same receptor system as a natural hormone while lasting far longer or behaving differently in practice.
Useful mental model
Natural signal → understood pathway → engineered medicine.
Many important peptide drugs began with a normal biological signal. The science then became an engineering problem: preserve the useful signal while improving stability, selectivity, duration or delivery.
The current era
Peptides are no longer a niche corner of medicine.
The FDA now counts well over one hundred approved peptide drug products designated as reference listed drugs. The field spans metabolic disease, endocrinology, oncology, reproductive health and other areas.
The recent visibility of GLP-1 and multi-receptor incretin medicines is a new chapter in a much older story, not the beginning of peptide science.
Key takeaways
- ✓Peptide medicine has more than a century of history.
- ✓Insulin proved that replacing a peptide signal could transform disease treatment.
- ✓Chemical synthesis and recombinant manufacturing made peptide drugs scalable.
- ✓Modern peptide drugs are often engineered analogues designed to improve stability, duration or delivery.
- ✓The current GLP-1 era sits on top of decades of peptide science.
Further reading
Lesson finished
Ready for the checkpoint?
The quiz opens on its own page. Get every answer correct to mark this lesson complete and continue.
Take lesson quiz →Previous
Why peptides are so interesting ←
Next lesson
The peptide landscape →
Continue when you are ready, or come back to this lesson whenever you need a refresher.